Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 20, 2009, Pages 8227-8232

  Ikeda, Koji ^a   Nakano, Ritsuko ^a   Uraoka, Maki ^a   Nakagawa, Yusuke ^a   Koide, Masahiro ^a   Katsume, Asako ^a   Minamino, Keizo ^c   Yamada, Eri ^c   Yamada, Haruhiko ^c   Quertermous, Thomas ^b   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; ISOPROTEIN; MATRIGEL; PROTEASOME; PROTEIN; PROTEIN ARIA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; APOPTOSIS REGULATOR THROUGH MODULATING IAP EXPRESSION GENE; ARTICLE; BLOOD VESSEL; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYMATIC DEGRADATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RETINOPATHY; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 66249131316     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806780106     Document Type: Article

References (34)

1. Tateishi-Yuyama E, et al. (2002) Therapeutic angiogenesis for patients with limb Ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 360:427-435.
2. Kastrup J (2003) Therapeutic angiogenesis in ischemic heart disease: Gene or recombinant vascular growth factor protein therapy? Curr Gene Ther 3:197-206.
3. Lei Y, Haider H, Shujia J, Sim ES (2004) Therapeutic angiogenesis, Devising new strategies based on past experiences, Basic Res Cardiol 99:121-132.
4. Verheul HM, Pinedo HM (2003) Vascular endothelial growth factor and its inhibitors, Drugs Today 39:81-93.
5. DeLisser HM, Newman PJ, Albelda SM (1993) Platelet endothelial cell adhesion molecule (CD31), Curr Top Microbiol Immunol 184:37-45.
6. Peters KG, et al. (2004) Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res 59:51-71.
7. Shlbuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469-478.
8. Tanaka K (1998) Molecular biology of the proteasome. Biochem Biophys Res Commun 247:537-541.
9. Yang Y, Fang S, Jensen JP, Welssman AM, Ashwell JD (2000) Ubiquitin protein ligase activity of IAPs and their degradation In proteasomes in response to apoptotic stimuli. Science 288:874-877.
10. Thompson SJ, Loftus LT, Ashley MD, Meller R (2008) Ubiquitin-proteasome system as a modulator of cell fate. Curr Opin Pharmacol 8:90-95.
11. Mao I, Liu J, Li X, Luo H (2008) REGgamma, a proteasome activator and beyond? Cell Mol Life Sci 65:3971-3980.
12. Zhao J, Tenev T, Martins LM, Downward J, Lemolne NR (2000) The ubiquitinproteasome pathway regulatessurvivin degradation Ina cell cycle-dependent manner. J Cell Sci 23:4363-4371.
13. Segura I, et al. (2002) Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis, FASEB J 16:833-841.
14. Pollman MJ, Naumovski L, Gibbons GH (1999) Endothelial cell apoptosis In capillary network remodeling. J Cell Physiol 178:359-370.
15. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-304.
16. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914-6925.
17. Ditzel M, Meier P (2002) IAP degradation: Decisive blow or altruistic sacrifice? Trends Cell Biol 12:449-452.
18. Vaux DL, Silke J (2005) IAPs, RINGs and ubiquitylation, Nat Rev Mol Cell Biol 6:287-297.
19. Sdek P, et al. (2005) MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein, Mol Cell 20:699-708.
20. Rousset R, Desbois C Bantignies F, Jalinot P (1996) Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381:328-331.
21. Touitou R, et al. (2001) A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J 20:2367-2375.
22. Duval H, Harris M, LI J, Johnson N, Print C (2003) New insights into the function and regulation of endothelial cell apoptosis. Anoiogenesis 6:171-183.
23. Choi ME, Ballermann BJ (1995) Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors, J Biol Chem 270:21144-21150.
24. Weihua Z, Tsan R, Schroit AJ, Fidler IJ (2005) Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling. Cancer Res 65:11529-11535.
25. de Graaf AO, de Witte T, Jansen JH (2004) Inhibitor of apoptosis proteins: New therapeutic targets in hematological cancer? Leukemia 18:1751-1759.
26. Wrzesien-Kus A Smolewski P, Sobczak-Pluta A, Wierzbowska A, Robak T (2004) The inhibitor of apoptosls protein family and its antagonists in acute leukemias, Apoptosis 9:705-715.
27. Akyurek N, Ren Y, Rassidakis GZ, Schlette EJ, Medeiros U (2006) Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer 107:1844-1851.
28. Rissanen TT, et al. (2005) Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 112:3937-3946.
29. Ikeda K, Quertermous T (2004) Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J Biol Chem 279:55315-55323.
30. Ikeda K, et al. (2006) Glia maturation factor-gamma is preferentially expressed In microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ Res 99:424-433.
31. Ikeda K, et al. (1999) Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 274:32469-32477.
32. Higuchi A, Yamada H, Yamada E, Jo N, Matsumura M (2008) Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-Induced retinopathy. Mol Vis 14:249-254.
33. Ozakl H, et al. (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156:697-707.
34. Seo MS, et al. (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol 154:1743-1753.